Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular proteins containing sulfur-bearing residues refer to a vast array of proteins that utilize the amino acids cysteine and methionine for structural and functional purposes. The sulfur atoms, particularly in the form of sulfhydryl (-SH) groups in cysteine, are essential for forming disulfide bonds that stabilize protein tertiary structure and for participating in redox reactions [1]. These residues are highly sensitive to oxidation and are primary targets for heavy metals like mercury, lead, and arsenic, which form stable mercaptides, thereby inactivating essential enzymes and transport proteins [2]. In toxicology and pharmacology, this group is often cited as the site of action for chelating agents like dimercaprol, which work by providing alternative sulfur-binding sites to sequester toxins away from cellular proteins [3]. Because this term describes a chemical characteristic shared by a significant portion of the proteome rather than a single entity, it is classified as a broad molecular category rather than a specific therapeutic target [4]. [1] https://doi.org/10.1093/jn/136.6.1636S [2] https://doi.org/10.1016/j.freeradbiomed.2017.01.015 [3] https://doi.org/10.3390/ijerph7072745 [4] https://doi.org/10.1016/j.freeradbiomed.2019.05.035
Chelating agents compete with cellular sulfur-bearing residues for heavy metal ions to prevent or reverse protein inactivation, while electrophilic drugs or toxins covalently bind to sulfhydryl groups to inhibit protein function.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular proteins containing sulfur-bearing residues.